Stem Cell Innovations Inc trades on the US exchange as stock symbol. Find any company using our search above.
BUSINESS OVERVIEW - Stem Cell Innovations Inc
Stem Cell Innovations, Inc. manufactures toxicity testing products for the pharmaceutical industry. The testing products indicate toxicity in drugs under development.
Latest News Stem Cell Innovations Inc
No stock or financial news could be found for Stem Cell Innovations Inc
Complete Profile Description of Stem Cell Innovations Inc
Stem Cell Innovations, Inc., a cell biology company, provides toxicology testing and discovery systems for drug discovery and development, food supplement, nutraceuticals, cosmetics, and chemical industries in the United States and internationally. It develops human cell based drug discovery solutions, including human cellular disease models and cell-based therapies. The company also provides PluriCells and derivatives, which generate a range of differentiated human cell types for drug discovery of various diseases that include Parkinson's, Huntington's disease, multiple sclerosis, and hearing loss; and ACTIVTox that eliminates toxic side effects of drugs. In addition, it offers PREDICTIVTox, a predictive database of structured toxicity information comprising various compounds that have been profiled using ACTIVTox; and human serum protein production services. The companys products and services are used in various applications, such as drug discovery process that includes target and molecule discovery, as well as validation, toxicology testing, and cell-based therapeutics. Stem Cell Innovations, Inc. was formerly known as Interferon Sciences, Inc. The company was founded in 1980 and is based in Houston, Texas with laboratories and additional offices in Scotch Plains, New Jersey; Houston, Texas; and Leiden, the Netherlands.